EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome

Philip E Mosley, Lachlan Webb, Anastasia Suraev, Leah Hingston, Tracy Turnbull, Kelley Foster, Emma Ballard, Lauren Gomes, Adith Mohan, Perminder S Sachdev, Richard Kevin, Rebecca Gordon und 2 weitere

NEJM Evidence · 22.08.2023 · 2 (9)

DOI: 10.1056/evidoa2300012 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 22.08.2023. Verfasst von Philip E Mosley und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. Hauptthemen laut MEDLINE: Tourette Syndrome, Tics, Cannabidiol. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tourette SyndromeTicsCannabidiolHumansDronabinolSeverity of Illness Index

Substanzen

CannabidiolDronabinol

Autor:innen und Institutionen

  • Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Wesley Medical Research Institute, Wesley Hospital, Auchenflower, QLD, Australia.
  • Queensland Brain Institute, University of Queensland, St. Lucia, QLD, Australia.
  • Australian eHealth Research Centre, CSIRO Health and Biosecurity, Herston, QLD, Australia.
  • Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • The Lambert Initiative for Cannabinoid Therapeutics, University of Sydney, Camperdown, NSW, Australia.

Zitieren

APA

Mosley, P. E., Webb, L., Suraev, A., Hingston, L., Turnbull, T., Foster, K., Ballard, E., Gomes, L., Mohan, A., Sachdev, P. S., Kevin, R., Gordon, R., Benson, M., & McGregor, I. S. (2023). Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome. NEJM Evidence, 2(9). https://doi.org/10.1056/evidoa2300012

Vancouver

Mosley PE, Webb L, Suraev A, Hingston L, Turnbull T, Foster K, et al. Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome. NEJM Evidence. 2023;2(9). doi:10.1056/evidoa2300012

BibTeX
@article{Mosley2023,
  author = {Mosley, Philip E and Webb, Lachlan and Suraev, Anastasia and Hingston, Leah and Turnbull, Tracy and Foster, Kelley and Ballard, Emma and Gomes, Lauren and Mohan, Adith and Sachdev, Perminder S and Kevin, Richard and Gordon, Rebecca and Benson, Melissa and McGregor, Iain S},
  title = {Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome},
  journal = {NEJM Evidence},
  year = {2023},
  volume = {2},
  number = {9},
  doi = {10.1056/evidoa2300012}
}
Kostenlos starten →